Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis

INTRODUCTION: The introduction of tumor necrosis factor-alpha (TNF-α) antagonists has substantially improved patient’s clinical outcome in rheumatoid arthritis (RA). However, nearly 20% to 40% of RA patients do not respond to anti-TNF-α treatment strategies. To identify valid predictors of TNF-α ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaschke, Sabine, Rinke, Kathinka, Maring, Michael, Flad, Thomas, Patschan, Susann, Jahn, Olaf, Mueller, Claudia A, Mueller, Gerhard A, Dihazi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383078/
https://www.ncbi.nlm.nih.gov/pubmed/25884688
http://dx.doi.org/10.1186/s13075-015-0553-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383078/
https://www.ncbi.nlm.nih.gov/pubmed/25884688
http://dx.doi.org/10.1186/s13075-015-0553-1

Ejemplares similares